Breast Neoplasms: all 12,820 studies

Page 48 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal CancerTerminatedNCT00305643Phase 3Results posted
• A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mgCompletedNCT00305448Phase 2Results posted
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast CancerCompletedNCT00304096Phase 1Results posted
• Doxil & Carboplatin Plus HER2+ in Metastatic Breast CancerCompletedNCT00303108Phase 2Results posted
• D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic PainTerminatedNCT00301080Phase 3Results posted
• Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast CancerCompletedNCT00300781Phase 2Results posted
• Trastuzumab and Oxaliplatin in Patients With Metastatic Breast CancerCompletedNCT00297596Phase 2Results posted
• Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other CancerCompletedNCT00296036Phase 3Results posted
• Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast CancerActive, not recruitingNCT00295893Phase 2Results posted
• Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00295867Phase 2Results posted
• Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic AcidCompletedNCT00295646Phase 3Results posted
• Secondary Adjuvant Long Term Study With ArimidexCompletedNCT00295620Phase 3Results posted
• Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast CancerCompletedNCT00293540Phase 3Results posted
• Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantCompletedNCT00293384Not applicableResults posted
• Protocol for Women at Increased Risk of Developing Breast CancerCompletedNCT00291694Phase 2Results posted
• Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast CancerCompletedNCT00291577Phase 1Results posted
• Protocol for Women at Increased Risk of Developing Breast CancerCompletedNCT00291135Phase 2Results posted
• Genistein in Preventing Breast Cancer in Women at High Risk for Breast CancerCompletedNCT00290758Phase 2Results posted
• Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in SituCompletedNCT00290745Phase 1/2Results posted
• Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast CancerCompletedNCT00290732Phase 1Results posted
• Phase 2 Study of Lovastatin as Breast Cancer ChemopreventionTerminatedNCT00285857Phase 2Results posted
• Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast CancerCompletedNCT00284180Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)CompletedNCT00281697Phase 3Results posted
• Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2CompletedNCT00281658Phase 3Results posted
• Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast CancerTerminatedNCT00281528Phase 2Results posted
• Partial Breast Irradiation With ChemotherapyCompletedNCT00278109Phase 1/2Results posted
• Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00274768Phase 2Results posted
• A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast CancerCompletedNCT00274469Phase 2Results posted
• Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast CancerCompletedNCT00274456Phase 2Results posted
• ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and LapatinibTerminatedNCT00272987Phase 3Results posted
• Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer PatientsCompletedNCT00270894Phase 2Results posted
• The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071)CompletedNCT00266799Phase 3Results posted
• Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00266110Phase 2Results posted
• Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00265759Phase 3Results posted
• Lapatinib for Brain Metastases In ErbB2-Positive Breast CancerCompletedNCT00263588Phase 2Results posted
• A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer PatientsTerminatedNCT00263211Phase 2Results posted
• Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast CancerCompletedNCT00262834Phase 2Results posted
• A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)Status unknownNCT00262067Phase 3Results posted
• Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast CancerCompletedNCT00259090Phase 2Results posted
• Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast CancerCompletedNCT00258960Phase 2Results posted
• Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast CancerCompletedNCT00258349Phase 1/2Results posted
• Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination TherapyCompletedNCT00256698Phase 3Results posted
• Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast CancerCompletedNCT00256243Phase 2Results posted
• Neoadjuvant Treatment of Breast CancerCompletedNCT00254592Phase 2Results posted
• Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase InhibitorsCompletedNCT00253422Phase 3Results posted
• PhII ICb With/Without Erbitux in MBC PtsActive, not recruitingNCT00248287Phase 2Results posted
• Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast CancerCompletedNCT00248170Phase 3Results posted
• Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast CancerCompletedNCT00246571Phase 2Results posted
• A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and CapecitabineCompletedNCT00246090Phase 2Results posted
• Understanding Shared Psychobiological PathwaysCompletedNCT00245219Not applicableResults posted
• Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for CancerCompletedNCT00245050Phase 3Results posted
• Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast CancerCompletedNCT00244933Phase 2Results posted
• A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)CompletedNCT00244881Phase 2Results posted
• Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast CancerCompletedNCT00243503Phase 2Results posted
• Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.CompletedNCT00240071Phase 2Results posted
• Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBCCompletedNCT00236899Phase 3Results posted
• Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast CancerCompletedNCT00232505Phase 2Results posted
• Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast CancerCompletedNCT00232479Phase 2Results posted
• The Role of Serotonin in Hot Flashes After Breast CancerCompletedNCT00228943Not applicableResults posted
• Lapatinib in Metastatic Breast Cancer Resistant to Hormone TherapyTerminatedNCT00225758Phase 2Results posted
• Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast CancerCompletedNCT00217672Phase 2Results posted
• Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT00217399Phase 1/2Results posted
• Multi-catheter High Dose Rate (HDR) Breast BrachytherapyTerminatedNCT00214149Phase 2Results posted
• Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast CancerCompletedNCT00213980Phase 2Results posted
• Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast CancerTerminatedNCT00210236Phase 3Results posted
• Radiofrequency of Breast Cancers in Non Surgical PatientsCompletedNCT00210223Not applicableResults posted
• Administration of Ketamine to Prevent the Post-operative PainCompletedNCT00210210Phase 3Results posted
• Randomized Phase II Trial Induction Therapy for Early Stage Breast CancerCompletedNCT00209092Phase 2Results posted
• Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer PatientsCompletedNCT00206518Phase 2Results posted
• Neoadjuvant GW572016 to Treat Breast CancerCompletedNCT00206427Phase 2Results posted
• Soy Isoflavones and Breast Cancer Risk ReductionCompletedNCT00204490Phase 2Results posted
• Soy Protein and Breast Cancer Risk ReductionCompletedNCT00204477Phase 2Results posted
• Primary Systemic Therapy in Operable/Locally Advanced Breast CancerCompletedNCT00203502Phase 2Results posted
• Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast CancerCompletedNCT00201864Phase 2Results posted
• Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast CancerCompletedNCT00201851Phase 3Results posted
• Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast CancerCompletedNCT00201773Phase 2Results posted
• Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast CancerCompletedNCT00201760Phase 2Results posted
• Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast CancerTerminatedNCT00195091Phase 2Results posted
• Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral NeuropathyCompletedNCT00195013Phase 3Results posted
• Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerTerminatedNCT00194792Phase 2Results posted
• Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryCompletedNCT00194779Phase 2Results posted
• Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast CancerCompletedNCT00193206Phase 2Results posted
• Docetaxel Plus Imatinib Mesylate in Metastatic Breast CancerCompletedNCT00193180Phase 2Results posted
• Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast CancerCompletedNCT00193063Phase 2Results posted
• Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast CancerCompletedNCT00193050Phase 2Results posted
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast CancerCompletedNCT00193037Phase 2Results posted
• Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st LineCompletedNCT00191854Phase 2Results posted
• Combination Chemotherapy for Metastatic Breast CancerCompletedNCT00191815Phase 2Results posted
• Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast CancerCompletedNCT00191789Phase 2Results posted
• A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast CancerCompletedNCT00191451Phase 2Results posted
• Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane RegimenCompletedNCT00191269Phase 2Results posted
• A Phase III Trial For Patients With Metastatic Breast CancerCompletedNCT00191152Phase 3Results posted
• A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer PatientsCompletedNCT00190671Phase 1/2Results posted
• Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal WomenCompletedNCT00186121Phase 2Results posted
• A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)TerminatedNCT00183963Phase 2Results posted
• Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerCompletedNCT00182793Phase 2Results posted
• Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian CancerCompletedNCT00182767Phase 1/2Results posted
• Radiation Therapy During Surgery in Treating Older Women With Invasive Breast CancerCompletedNCT00182728Not applicableResults posted
• Prone Breast Irradiation for Pendulous BreastsCompletedNCT00181363Not applicableResults posted
• Docetaxel Alone or in Combination With Vaccine to Treat Breast CancerCompletedNCT00179309Phase 2Results posted

← Breast Neoplasms overview